Filter
961
Text search:
European
Medicines
Agency
Featured
Recommendations
100
New Publications
212
Language
Document type
No document type
424
Studies & Reports
226
Guidelines
154
Manuals
56
Strategic & Response Plan
43
Fact sheets
29
Situation Updates
15
Training Material
9
Resource Platforms
3
Brochures
1
Online Courses
1
Countries / Regions
Western and Central Europe
60
Global
46
Ukraine
38
Eastern Europe
25
Africa
22
Sierra Leone
20
Nigeria
18
Liberia
16
Ghana
16
Kenya
16
Nepal
14
Ethiopia
12
Myanmar / Burma
12
Zambia
11
Syria
10
Latin America and the Carribbean
10
India
9
Germany
9
Eastern Europe and Central Asia
9
Guinea
8
Uganda
8
Philippines
8
Rwanda
8
South Africa
8
Bangladesh
8
Moldova
8
Congo, Democratic Republic of
7
West and Central Africa
7
Zimbabwe
6
Thailand
6
Indonesia
6
Burkina Faso
5
South Sudan
5
Tanzania
5
Malawi
5
East and Southern Africa
5
South–East Asia Region
5
Russia
5
Senegal
4
Jordan
4
Namibia
4
Brazil
4
Hungary
4
Botswana
4
Middle East and North Africa
4
Asia
4
Venezuela
4
Poland
4
Georgia
4
Pakistan
3
Cambodia
3
North Macedonia
3
Yemen
3
Albania
3
Romania
3
Jamaica
3
Morocco
2
Afghanistan
2
Lebanon
2
Mozambique
2
Sudan
2
Argentina
2
Eswatini/ Swaziland
2
Serbia
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Bulgaria
2
Iran
2
Vietnam
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Turkey
1
Egypt
1
China
1
Benin
1
Central African Republic
1
Colombia
1
Ecuador
1
Bolivia
1
Greece
1
Lesotho
1
Mexico
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Mongolia
1
Slovakia
1
Kyrgyzstan
1
Australia
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
259
Clinical Guidelines
111
Public Health
57
Women & Child Health
41
Key Resources
28
Pharmacy & Technologies
23
Capacity Building
9
Toolboxes
AMR
90
COVID-19
89
TB
84
HIV
79
Mental Health
66
Pharmacy
53
Conflict
45
Rapid Response
32
Planetary Health
31
Ebola
27
Global Health Education
26
Refugee
23
Disability
18
NCDs
18
Health Financing Toolbox
15
Caregiver
14
NTDs
13
Natural Hazards
9
Zika
7
Specific Hazards
5
Polio
4
Cholera
2
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal
...
A consolidated set of reproductive health kits for use by humanitarian agencies. These kits are intended to speed up the provision of appropriate reproductive health services in emergency and refugee situations.
Childhood obesity is a major public health problem globally, which could undermine progress towards achieving the Sustainable Development Goals. Prevention is recognized as the most efficient means of curbing the epidemic; however, given the scale of the problem and the many children who need profes
...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
The ERP approach seeks to improve effectiveness by reducing both time and effort, enhancing predictability through establishing predefined roles, responsibilities and coordination mechanisms. The Emergency Response Preparedness Plan (ERPP) has four main components: i) Risk Assessment, ii) Minimum Pr
...
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe
...
EMCDDA Insights - 11
Accessed: 14.03.2019
A summary of the national drug situation
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infecti
...
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended
...
Accessed: 26.11.2019
This background document (EUR/RC72/BG/7) was considered and adopted by the WHO Regional Committee for Europe at its 72nd session (Tel Aviv, Israel, 12–14 September 2022), together with the working document (EUR/RC72/7) and information document (EUR/RC72/INF./4). The Regiona
...
23 April 2020EMA/202483/2020 Rev
Chloroquine and hydroxychloroquine are known to potentially cause heart rhythm problems, and these could be exacerbated if treatment is combined with other medicines, such as the antibiotic azithromycin, that have s
...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi
...
